| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 11/15/2012 | US20120288895 Compositions and Methods for Modulating Hemostasis Using Variant Forms of Activated Factor V | 
| 11/15/2012 | US20120288894 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity | 
| 11/15/2012 | US20120288893 Seed-specific expression vector and its construction methods and applications | 
| 11/15/2012 | US20120288892 Methods for Producing Polypeptidies in Protease-Deficient Mutants of Trichoderma | 
| 11/15/2012 | US20120288882 Type iv secretion system proteins in sero-detection of anaplasma phagocytophilum | 
| 11/15/2012 | US20120288564 Interpenetrating polymer network comprising fibrin | 
| 11/15/2012 | US20120288526 Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods | 
| 11/15/2012 | US20120288502 Compositions and methods for improving potency and breadth of hiv antibodies | 
| 11/15/2012 | US20120288477 Type of consensus interferon and preparation method thereof | 
| 11/15/2012 | CA2835630A1 Modified biotin-binding protein, fusion proteins thereof and applications | 
| 11/15/2012 | CA2835603A1 Antibody capable of specifically recognizing transferrin receptor | 
| 11/15/2012 | CA2835506A1 Monoclonal antibody for acetylamantadine | 
| 11/14/2012 | EP2522727A1 Highly functional bispecific antibody | 
| 11/14/2012 | EP2522358A1 Peptides against rotavirus infection | 
| 11/14/2012 | EP2521787A2 Enhanced protein expression | 
| 11/14/2012 | EP2521704A1 Process for the specific isotopic labeling of methyl groups of val, leu and ile | 
| 11/14/2012 | EP1707627B1 Antagonistic anti-CD40 antibody mutant | 
| 11/14/2012 | CN1890367B Surfactant-tolerant cellulase and method of converting the same | 
| 11/14/2012 | CN102782149A Engineered anti-TSLP antibody | 
| 11/14/2012 | CN102782148A Antikine antibodies that bind to multiple CC chemokines | 
| 11/14/2012 | CN102782132A Orthogonal Q-ribosomes | 
| 11/14/2012 | CN102782131A Modified antibody composition | 
| 11/14/2012 | CN102782130A High-expression promoter derived from kluyveromyces marxianus | 
| 11/14/2012 | CN102782125A Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof | 
| 11/14/2012 | CN102781964A Anti-CDH3 antibodies and uses thereof | 
| 11/14/2012 | CN102778565A Rapid 1-type dengue gold-marking diagnosis test paper strip | 
| 11/14/2012 | CN102776262A Preparation method of high-F-value tuna oligopeptide | 
| 11/14/2012 | CN102776261A Process for preparing human G-CSF | 
| 11/14/2012 | CN102776260A Method for effectively expressing recombinant human coagulation factor VIII | 
| 11/14/2012 | CN102776259A Preparation method of long insulin-like growth factor 1 mutant | 
| 11/14/2012 | CN102776258A Fermentation method for coproduction of S-adenosyl-L-methionine and glutathione | 
| 11/14/2012 | CN102776218A Mutant receptors and their use in a nuclear receptor-based inducible gene expression system | 
| 11/14/2012 | CN102776147A Gene-recombined peoriae paenibacillus, and construction method and application thereof | 
| 11/14/2012 | CN102190732B PGBD-2 fusion defensin, and preparation method and application thereof | 
| 11/14/2012 | CN102121029B Plant expression vector and construction method thereof, and method for producing chicken alpha interferon by utilizing crowtoe as bioreactor | 
| 11/14/2012 | CN101748179B Preparation method of feather protein peptide | 
| 11/14/2012 | CN101747416B B-cell antigenic multi-epitope peptide linked in tandem in OmpU of vibrio mimicus, making method and application thereof | 
| 11/14/2012 | CN101679518B The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof | 
| 11/14/2012 | CN101608206B Method for preparing soy protein immune-active peptides and product thereof | 
| 11/14/2012 | CN101402921B Method for producing gamma-glutamylcycteine | 
| 11/13/2012 | US8309795 Method for secretory production of glycoprotein having human-type sugar chain using plant cell | 
| 11/13/2012 | US8309693 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto | 
| 11/13/2012 | US8309688 Monkey homolog of human oncostatin M and methods of use thereof | 
| 11/13/2012 | US8309686 Neurotoxins with enhanced target specificity | 
| 11/13/2012 | US8309328 Compositions and methods for production of fermentable sugars | 
| 11/13/2012 | US8309327 Method of producing an immunogenic composition | 
| 11/13/2012 | US8309326 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | 
| 11/13/2012 | US8309325 Efficient production of heterologous proteins using mannosyl transferase inhibitors | 
| 11/13/2012 | US8309324 Promoters and proteins from Clostridium thermocellum and uses thereof | 
| 11/13/2012 | US8309315 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods | 
| 11/13/2012 | US8309102 Methods and compositions for immunizing against Chlamydia infection | 
| 11/13/2012 | US8309100 Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains | 
| 11/13/2012 | US8309087 Treatment with anti-ErbB2 antibodies | 
| 11/13/2012 | CA2641565C Nel-related proteins type 1 and 2, and polynucleotides encoding them | 
| 11/13/2012 | CA2478414C Selective targeting of tumor vasculature using antibody molecules | 
| 11/13/2012 | CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies | 
| 11/13/2012 | CA2413576C Streptococcus pyogenes antigens | 
| 11/13/2012 | CA2397675C Altered strain of the modified vaccinia virus ankara (mva) | 
| 11/13/2012 | CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation | 
| 11/08/2012 | WO2012151481A1 Compositions for inhibiting masp-2 dependent complement acitivation | 
| 11/08/2012 | WO2012150421A1 Method for obtaining an alfalfa protein extract and reusable co-products | 
| 11/08/2012 | WO2012103260A3 High-throughput methods to produce, validate and characterize mmabs | 
| 11/08/2012 | US20120284871 Protein expression systems | 
| 11/08/2012 | US20120284810 Anti-cd151 antibodies and their use in the treatment of cancer | 
| 11/08/2012 | US20120283420 Production of Multi-Antennary N-Glycan Structures in Plants | 
| 11/08/2012 | US20120283414 Monoclonal Antibodies for Ebola and Marburg Viruses | 
| 11/08/2012 | US20120283412 Orphan nuclear receptor | 
| 11/08/2012 | US20120283408 Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein | 
| 11/08/2012 | US20120283318 Replicating viral vectors for gene therapy | 
| 11/08/2012 | US20120283314 Sodium channel protein type iii alpha-subunit splice variant | 
| 11/08/2012 | US20120282689 Expanding the Eukaryotic Genetic Code | 
| 11/08/2012 | US20120282654 Antibody purification | 
| 11/08/2012 | US20120282653 Method for making polypeptides | 
| 11/08/2012 | US20120282652 Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties | 
| 11/08/2012 | US20120282624 Integration of genes into the chromosome of saccharopolyspora spinosa | 
| 11/08/2012 | US20120282464 Spherical Protein Particles and Methods of Making and Using Them | 
| 11/08/2012 | US20120282290 Mycobacterial Vaccines | 
| 11/08/2012 | US20120282289 Staphylococcal antigens | 
| 11/08/2012 | US20120282287 Novel Flavivirus Antigens | 
| 11/08/2012 | US20120282285 Masp isoforms as inhibitors of complement activation | 
| 11/08/2012 | US20120282271 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein | 
| 11/08/2012 | US20120282268 Novel Cell Wall Components of Enterococci and Uses Thereof | 
| 11/08/2012 | US20120282263 Compositions for inhibiting masp-2 dependent complement activation | 
| 11/08/2012 | US20120282254 Cd127 binding proteins | 
| 11/08/2012 | US20120282253 Interleukin-10 antibodies | 
| 11/08/2012 | US20120282246 Compositions and methods for antibody and ligand identification | 
| 11/08/2012 | US20120282231 Human lysosomal proteins from plant cell culture | 
| 11/08/2012 | US20120282177 ROR1 as Therapeutic and Diagnostic Target | 
| 11/08/2012 | US20120282170 Anti- tnf antibodies, compositions, methods and uses | 
| 11/08/2012 | CA2832871A1 Compositions for inhibiting masp-2 dependent complement activation | 
| 11/07/2012 | EP2520648A1 Anti-iga1 antibody | 
| 11/07/2012 | EP2520589A1 Anti-cd27 antibody | 
| 11/07/2012 | EP2520586A1 Method of producing factor VIII proteins by recombinant methods | 
| 11/07/2012 | EP2520310A1 Cellular permissivity factor for viruses, and uses thereof | 
| 11/07/2012 | EP2519542A1 Anti-cdh3 antibodies and uses thereof | 
| 11/07/2012 | CN102770555A Improved bacterial membrane protein secrection | 
| 11/07/2012 | CN102770554A Antibody glycosylation variants | 
| 11/07/2012 | CN102770529A Human monoclonal antibodies to human nucleolin | 
| 11/07/2012 | CN102770448A Compositions and methods for the detection of antibodies to native human leukocyte antigen | 
| 11/07/2012 | CN102766671A Method for extracting proteins from vitamin C fermented mash |